abstract |
The present invention relates to a novel salt of tegaserod, namely tegaserod suberate,and to processes for the preparation thereof. The invention also relates to crystalline forms of the novel salt and to pharmaceutical compositions comprising thenovel salt. Further, the invention relates to uses of said compositions in treating patients suffering from gastrointestinal disorders. |